UNGMEDIUM SIGNALFINANCIAL10-K

UNG experienced a substantial increase in outstanding shares alongside meaningful declines in assets and deposits, indicating significant fund outflows and potential structural changes.

The 47% increase in outstanding shares (from 24.1M to 35.5M) combined with declining assets suggests UNG faced redemption pressures that required share creation while the underlying fund size contracted. The updated language around benchmark contract transitions and tracking methodology indicates operational refinements to improve performance alignment with natural gas futures.

Comparing 2026-02-27 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

UNG's financial position contracted meaningfully across key metrics, with total assets declining 26.6% to $579.5M and deposits falling substantially to $132.2M. Net income was nearly halved to $34.2M, while cash and equivalents decreased 26.1% to $438.5M. The overall picture signals a fund under redemption pressure, requiring share creation to meet outflows while managing a smaller asset base.

FINANCIAL STATEMENT CHANGES
Total Deposits
Balance Sheet
-68.5%
$419.3M$132.2M

Deposits declined 68.5% — significant outflows warrant immediate investigation into funding stability.

Net Income
P&L
-47.5%
$65.1M$34.2M

Net income declined 47.5% — review whether driven by operations, interest costs, or non-recurring items.

Total Liabilities
Balance Sheet
-37.5%
$46.2M$28.8M

Liabilities reduced 37.5% — deleveraging improves balance sheet strength and financial flexibility.

Total Assets
Balance Sheet
-26.6%
$790.0M$579.5M

Total assets contracted 26.6% — asset sales, write-downs, or balance sheet optimization underway.

Cash & Equivalents
Balance Sheet
-26.1%
$593.5M$438.5M

Cash decreased 26.1% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-28
ADDED
The registrant had 35,546,103 outstanding shares as of February 23, 2026.
Market conditions that USCF currently anticipates could cause UNG to invest in Other Natural Gas-Related Investments include, but are not limited to, those allowing UNG to obtain greater liquidity or to execute transactions with more favorable pricing.
Market conditions that USCF currently anticipates could cause UNG to invest in Other Natural Gas- Related Investments include, but are not limited to, those allowing UNG to obtain greater liquidity or to execute transactions with more favorable pricing.
The Benchmark Futures Contract is changed from the near month contract to the next month contract over a four-day period.
USCF endeavors to place UNG s trades in Natural Gas Interests and otherwise manage UNG s investments so that A will be within plus/minus ten percent (10%) of B, where: A is the average daily percentage change in UNG s per share NAV for any period of 30 successive valuation days; i.e., any NYSE Arca trading day as of which UNG calculates its per share NAV; and B is the average daily percentage change in the price of the Benchmark Futures Contract over the same period.
+7 more — sign up free →
REMOVED
The registrant had 24,146,103 outstanding shares as of Febuary 24, 2025.
On day 4, the Benchmark Futures Contract is the next month contract to expire at that time and that contract remains the Benchmark Futures Contract until the beginning of the following month s change in the Benchmark Futures Contract over a four-day period.
USCF believes that market arbitrage opportunities will cause the daily changes in UNG s share price on the NYSE Arca, on a percentage basis, to closely track the daily changes in UNG s per share NAV.
Demand for petroleum products by consumers, as well as agricultural, manufacturing and transportation industries, determines demand for crude oil by refiners.
As of December 31, 2024, UNG held 14,459 NYMEX natural gas Futures NG contracts.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →